2014
DOI: 10.1016/j.jalz.2014.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

Abstract: Scientific evidence continues to demonstrate the linkage of vascular contributions to cognitive impairment and dementia such as Alzheimer's disease. In December, 2013, the Alzheimer's Association, with scientific input from the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute from the National Institutes of Health, convened scientific experts to discuss the research gaps in our understanding of how vascular factors contribute to Alzheimer's disease and re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

8
435
0
6

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 521 publications
(449 citation statements)
references
References 95 publications
8
435
0
6
Order By: Relevance
“…146 More specifically, several top priority objectives were recognized in the field: (1) animal models to understand the mechanistic link between cerebrovascular dysfunction and cognitive decline and to investigate the neuropathologic time course of neuronal and white matter injury. Smallvessel disease models mimicking human AD-related and mixed dementias are particularly needed; (2) biomarkers capable of detecting preclinical dementia are necessary, as early detection is the key to future therapeutic interventions.…”
Section: Discussionmentioning
confidence: 99%
“…146 More specifically, several top priority objectives were recognized in the field: (1) animal models to understand the mechanistic link between cerebrovascular dysfunction and cognitive decline and to investigate the neuropathologic time course of neuronal and white matter injury. Smallvessel disease models mimicking human AD-related and mixed dementias are particularly needed; (2) biomarkers capable of detecting preclinical dementia are necessary, as early detection is the key to future therapeutic interventions.…”
Section: Discussionmentioning
confidence: 99%
“…WMH also occur in neuroinflammatory diseases such as multiple sclerosis (Sarbu et al, 2016), and in neurodegenerative diseases (Filley & Fields, 2016). Research into the pathological correlates of WMH in vascular dementia and sporadic and familial Alzheimer’s disease (AD) is well-established (McAleese et al, 2015, 2017; Ryan et al, 2015; Snyder et al, 2015). However, WMH are less commonly seen in frontotemporal dementia (FTD).…”
Section: Introductionmentioning
confidence: 99%
“…A large body of evidence derived from both clinical and experimental studies demonstrate that aging significantly impairs neurovascular coupling responses, which likely contribute to cognitive decline in the elderly (Balbi et al 2015;Fabiani et al 2013;Sorond et al 2013;Tong et al 2012;Toth et al 2014;Zaletel et al 2005;Park et al 2007). There is also growing evidence for microvascular pathophysiological alterations having a causal role in the development of cognitive decline associated with Alzheimer's disease (AD) (Tarantini et al 2016;Snyder et al 2015). …”
mentioning
confidence: 99%